CSL heart drug flops, taking share price with it

2 minute read


It was a bad day for the Aussie pharma, but a net profit of $1.9 billion in the second half of 2023 will keep everyone in a job.


It was a bad day for the Aussie pharma, but a net profit of $1.9 billion in the second half of 2023 will keep everyone in a job.

This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.

End of content

No more pages to load

Log In Register ×